UnitedHealth Group Incorporated (NYSE:UNH) issued its full 2022-year EPS guidance, expecting it to range from $21.10 to $21.60, compared to the consensus estimate of $21.63. The new guidance is generally in line with prior comments that prior consensus of $21.64 would be at the top end of the range. The new outlook equates to 13% growth over 2021 guidance of $18.75-$18.90, raised from $18.50-$18-9. The growth is within the company's long-term EPS growth range target of 13-16%. Revenues are expected to be between $317 billion and $320 billion, compared to the Street estimate of $311 billion.